Brief: Chr. Hansen Q2 EBIT Ex-Items Down At EUR 70.1 Mln

Chr Hansen Holding A/S

15/04/2021 07:13

April 15 (Reuters) - Chr Hansen Holding A/S  CHRH.CO :
    * REG-CHR. HANSEN HOLDING A/S INTERIM REPORT Q2 2020/21
    * EXPECT THAT Q4 TO BE STRONGER OF TWO REMAINING QUARTERS,
PRIMARILY AS Q3 OF LAST YEAR HAD A TAILWIND EFFECT FROM
CUSTOMERS BUILDING COVID-19 RELATED SAFETY INVENTORIES
    * Q2 2020/21 ORGANIC SALES GROWTH WAS 10%, EQUALLY SPLIT
BETWEEN
VOLUME/MIX AND PRICE, AND DRIVEN BY HEALTH & NUTRITION WHICH
DELIVERED 14% GROWTH WHILE FOOD CULTURES & ENZYMES DELIVERED 8%
GROWTH
    * FULL-YEAR OUTLOOK FOR ORGANIC GROWTH ADJUSTED TO 6-8%
(PREVIOUSLY 5-8%), FREE CASH FLOW NARROWED UPWARDS TO EUR
140-160 MIO, EBIT MARGIN GUIDANCE UNCHANGED, AND IMPACTS FROM
ACQUISITIONS ALSO UNCHANGED FROM Q1
    * Q2 REVENUE EUR 260.0 MILLION VERSUS EUR 239.6 MILLION YEAR
AGO
    * IN Q3 WE WILL BE LAUNCHING NEXT GENERATION OF
BIOPROTECTION FOR
FERMENTED MILKS AND CERTAIN CHEESES
    * Q2 EBIT EX-ITEMS EUR 70.1 MILLION VERSUS EUR 77.1 MILLION
YEAR
AGO
    * Q2 PROFIT FROM CONTINUING OPERATIONS EUR 46.1 MILLION
VERSUS EUR
54.8 MILLION YEAR AGO

Source text for Eikon:  ID:nGNE2pWK9z 
Further company coverage:  CHRH.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))